These findings collectively demonstrate that the action of NLRP3 inflammasome in AD contributes to amyloid and tau pathology through the modulation of the clearance activities of microglia, Aβ seeding, and kinase activities. The gene discussed is NLRP3; the disease is Alzheimer disease.